BARD1 and breast cancer: Three other studies of BC cases from Nordic [14], Polish [17] and mixed populations [80] found that carriers of the BARD1 c.1670G>C; p.Cys557Ser variant and a BRCA1 or BRCA2 pathogenic variant did not confirm this finding.